Innovative, long-acting treatments – for patients and society
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn more
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care.
Events
Upcoming events
-
14Sep
Morgan Stanley Annual Global Healthcare Conference
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in New York, 14 September, at 10.05pm CET. The presentation can be seen by the conference participants.
-
17Sep
ABG Sundal Collier Small & Mid Cap Seminar
Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 17 September. The presentation can be seen by the conference participants. More information will follow closer to the event.
-
05Nov
Interim Report January-September 2026
The interim report January-September is published at 7.00 am CET on 5 November 2026.
Latest financial report
Camurus’ Interim Report Second Quarter 2026
15 July 2026
Annual Report 2025
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainability
Our approach to sustainability
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
